These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8909368)

  • 1. Efficacy and tolerability of tacrine in nursing home residents with Alzheimer's dementia.
    Woo JK; Lantz MS; Marchello V; Libow LS
    J Am Geriatr Soc; 1996 Nov; 44(11):1411-2. PubMed ID: 8909368
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurology "with the bark off": tacrine, nursing home residents, and health services research.
    Phillips CD; Knopman DS
    Neurology; 1999 Jan; 52(2):227-30. PubMed ID: 9932935
    [No Abstract]   [Full Text] [Related]  

  • 3. Is donepezil therapy associated with reduced mortality in nursing home residents with dementia?
    Gasper MC; Ott BR; Lapane KL
    Am J Geriatr Pharmacother; 2005 Mar; 3(1):1-7. PubMed ID: 16089241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). The efficacy of Tacrine and the measurement of outcomes of Alzheimer's disease.
    Int J Technol Assess Health Care; 1998; 14(2):398-9. PubMed ID: 9678977
    [No Abstract]   [Full Text] [Related]  

  • 5. Guidelines for the use of tacrine in Alzheimer's disease: clinical application and effectiveness. Johns Hopkins Dementia Research Clinic.
    Lyketsos CG; Corazzini K; Steele CD; Kraus MF
    J Neuropsychiatry Clin Neurosci; 1996; 8(1):67-73. PubMed ID: 8845704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance to tacrine, arterial hypotension and leuko-araiosis in Alzheimer's disease.
    Lebert F; Mouly C; Pasquier F
    Age Ageing; 1998 Sep; 27(5):654. PubMed ID: 12675108
    [No Abstract]   [Full Text] [Related]  

  • 7. Tacrine therapy is associated with reduced mortality in nursing home residents with dementia.
    Ott BR; Lapane KL
    J Am Geriatr Soc; 2002 Jan; 50(1):35-40. PubMed ID: 12028244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Tacrine for Alzheimer's disease.
    Qizilbash N; Birks J; Lopez Arrieta J; Lewington S; Szeto S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD000202. PubMed ID: 17636619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the value of therapeutic monitoring of tacrine in Alzheimer's disease.
    Roberts CJ; Ford JM; Truman CA; Scott M; Mäkelä PM; Wilcock GK
    Eur J Clin Pharmacol; 1998; 54(9-10):721-4. PubMed ID: 9923574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of evidence-based principles of care in older persons (issue 5): Alzheimer's disease.
    Zarowitz BJ; Stefanacci R; Hollenack K; O'Shea T; Gruber J; Tangalos EG
    J Am Med Dir Assoc; 2007 Mar; 8(3):183-93. PubMed ID: 17349948
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic results: tacrine].
    Ventura M; Sternon J
    Rev Med Brux; 1997 Dec; 18(6):394-7. PubMed ID: 9481161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic potential of tacrine.
    Kurz A
    J Neural Transm Suppl; 1998; 54():295-9. PubMed ID: 9850938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrine: a second look. An outdated drug to be discarded.
    Prescrire Int; 1999 Feb; 8(39):16-8. PubMed ID: 10557569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Tacrine for treatment of sleep disturbance in dementia".
    Gillman PK
    J Am Geriatr Soc; 1997 Oct; 45(10):1286. PubMed ID: 9329501
    [No Abstract]   [Full Text] [Related]  

  • 15. Alzheimer's disease.
    Kennedy-Malone LM; Fletcher K
    Lippincotts Prim Care Pract; 1999; 3(2):163-8. PubMed ID: 10426059
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term tacrine treatment effects.
    Knopman D; Schneider L; Davis K; Gracon S; Smith F
    Neurology; 1998 Feb; 50(2):567-8. PubMed ID: 9484404
    [No Abstract]   [Full Text] [Related]  

  • 17. Alzheimer's drug update: learn what drugs look promising.
    Lile J
    Nursing; 1997 Feb; 27(2):32lll-32nnn. PubMed ID: 9171601
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease.
    Patocka J; Jun D; Kuca K
    Curr Drug Metab; 2008 May; 9(4):332-5. PubMed ID: 18473751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype.
    Sjögren M; Hesse C; Basun H; Köl G; Thostrup H; Kilander L; Marcusson J; Edman A; Wallin A; Karlsson I; Troell M; Wachtmaister G; Ekdahl A; Olofsson H; Sandström A; Andreasen N; Minthon L; Blennow K
    J Neural Transm (Vienna); 2001; 108(4):451-8. PubMed ID: 11475012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed-model analysis of incomplete longitudinal data from a high-dose trial of tacrine (Cognex) in Alzheimer's patients.
    Smith F
    J Biopharm Stat; 1996 Mar; 6(1):59-67. PubMed ID: 8838779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.